Gateway Advisory’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-20,170
Closed -$101K 116
2021
Q3
$101K Buy
+20,170
New +$116K 0.02% 113
2020
Q4
Sell
-17,000
Closed -$60K 76
2020
Q3
$60K Sell
17,000
-6,900
-29% -$32.8K 0.01% 65
2020
Q2
$119K Hold
23,900
0.03% 59
2020
Q1
$81K Buy
+23,900
New +$103K 0.03% 54
2018
Q1
Sell
-15,570
Closed -$179K 92
2017
Q4
$179K Buy
+15,570
New +$232K 0.05% 88
2016
Q2
Sell
-6,054
Closed -$203K 47
2016
Q1
$203K Buy
+6,054
New +$191K 0.1% 35

Other funds holding PGEN

Gateway Advisory's PGEN Position: Q4 2021 in Review

Gateway Advisory sold out of Precigen (PGEN) in Q4 2021, closing a stake of 20,170 shares — an estimated $101K sold.

Gateway Advisory first reported a position in PGEN in Q1 2016 and held it in 6 quarters. The position peaked at $203K in Q1 2016. 168 funds tracked by Wall St. Rank hold PGEN as of Q4 2021.

  • Gateway Advisory reported no remaining Precigen position as of Q4 2021 after selling out during the quarter.
  • Gateway Advisory sold 20,170 Precigen shares in Q4 2021, an estimated $101K.
  • Gateway Advisory first reported a position in Precigen in Q1 2016 and held it in 6 quarters.
  • Gateway Advisory's Precigen position peaked at $203K in Q1 2016.
  • 168 funds tracked by Wall St. Rank held Precigen as of Q4 2021.

Based on Gateway Advisory's 13F filing for Q4 2021, filed 14 Jan 2022.